{"gene":"JARID2","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":2010,"finding":"JARID2 forms a stable complex with PRC2 (containing EZH2, SUZ12, EED) in ES cells, is required for PRC2 binding to >90% of PcG target genes genome-wide, and is sufficient to recruit PcG proteins to a heterologous promoter; inhibition of JARID2 causes major loss of PRC2 binding and reduction of H3K27me3 at target genes.","method":"Co-immunoprecipitation, genome-wide ChIP-seq, heterologous promoter recruitment assay, shRNA knockdown with H3K27me3 ChIP","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, genome-wide ChIP-seq, functional recruitment assay, replicated across multiple contemporaneous studies","pmids":["20075857"],"is_preprint":false},{"year":2009,"finding":"Jarid2 is a PRC2 subunit in ES cells that promotes PRC2 recruitment to target genes while simultaneously inhibiting PRC2 histone methyltransferase activity in vitro, acting as a 'molecular rheostat' that calibrates PRC2 function at developmental genes.","method":"Co-IP to establish PRC2 subunit status, genome-wide ChIP-seq (Jarid2, Ezh2, Suz12), in vitro histone methyltransferase activity assay with and without Jarid2, Xenopus knockdown","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro enzymatic assay combined with genome-wide ChIP-seq and genetic knockdown, replicated across contemporaneous studies","pmids":["20064375"],"is_preprint":false},{"year":2010,"finding":"Jarid2 is a novel subunit of PRC2 required for co-recruitment of PRC1 and RNA Polymerase II (Ser5-phosphorylated) to developmental genes in ES cells; Jarid2-deficient ES cells show reduced H3K4me2/me3 and H3K27me3 marking and loss of PRC1/PRC2 occupancy.","method":"ChIP-seq, ChIP-PCR, genetic knockout (Jarid2-deficient ES cells), immunofluorescence","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined chromatin phenotype, genome-wide occupancy analysis, replicated across contemporaneous studies","pmids":["20473294"],"is_preprint":false},{"year":2015,"finding":"JARID2 is methylated by PRC2 (EZH2); this methylation is recognized by the EED subunit of PRC2 and triggers allosteric activation of PRC2 enzymatic activity. Jarid2 methylation promotes PRC2 activity at loci devoid of H3K27me3 and is required for correct H3K27me3 deposition during cell differentiation.","method":"In vitro methylation assay, mass spectrometry identification of methylated residue, EED binding assay, allosteric activation assay, cell differentiation H3K27me3 ChIP","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with biochemical identification of modification site, functional allosteric assay, and cellular validation","pmids":["25620564"],"is_preprint":false},{"year":2016,"finding":"Jarid2 contains a ubiquitin interaction motif (UIM) at its amino-terminus that directly binds mono-ubiquitylated H2A lysine 119 (H2AK119u1), mediating PRC2 localization to H2AK119u1-marked chromatin both in vitro and in vivo, thereby linking PRC1 and PRC2 activities.","method":"Identification of UIM by sequence analysis, in vitro ubiquitin binding assay, Co-IP, ChIP in cells with H2AK119u1 manipulation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro binding with defined domain, in vivo ChIP validation, mutagenesis of UIM domain","pmids":["27892467"],"is_preprint":false},{"year":2018,"finding":"Cryo-EM structures of human PRC2 with cofactors JARID2 and AEBP2 show that methylated JARID2 mimics a methylated H3 tail to stimulate PRC2 activity; AEBP2 interacts with RBAP48 mimicking an unmodified H3 tail; SUZ12 interacts with all other subunits and stabilizes the complex.","method":"Cryo-electron microscopy structure determination, functional validation of cofactor interactions","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure with functional mechanistic interpretation, peer-reviewed","pmids":["29348366"],"is_preprint":false},{"year":2021,"finding":"Cryo-EM structure of PRC2 with JARID2 and AEBP2 bound to an H2AK119ub1-containing nucleosome reveals that JARID2 and AEBP2 each interact with one ubiquitin and the H2A-H2B surface; JARID2 stimulates PRC2 through interactions with both EED and H2AK119-ubiquitin; the presence of these cofactors partially overcomes inhibitory effects of H3K4me3 and H3K36me3 on core PRC2.","method":"Cryo-electron microscopy with designer nucleosome substrates, in vitro PRC2 activity assays","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution cryo-EM structure combined with in vitro enzymatic assays","pmids":["33479123"],"is_preprint":false},{"year":2013,"finding":"A 30-amino-acid region of JARID2 mediates interactions with long noncoding RNAs (lncRNAs); lncRNA presence stimulates JARID2-EZH2 interactions in vitro and JARID2-mediated PRC2 recruitment to chromatin in vivo. The lncRNA Meg3 (from Dlk1-Dio3 locus) interacts with PRC2 via JARID2, and loss of MEG3 alters JARID2, PRC2, and H3K27me3 chromatin distribution.","method":"RNA immunoprecipitation (native and cross-linked), in vitro JARID2-EZH2 interaction assay with/without lncRNA, ChIP in cells lacking MEG3","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution of lncRNA-stimulated interaction, native and crosslinked RIP, in vivo ChIP validation","pmids":["24374312"],"is_preprint":false},{"year":2014,"finding":"Jarid2 is an important mediator of Xist-induced PRC2 targeting to the inactive X chromosome during X-chromosome inactivation. The B and F repeats of Xist RNA are critical for Jarid2 recruitment via its unique N-terminal domain; Xist-induced Jarid2 recruitment occurs chromosome-wide independently of functional PRC2, and Jarid2 loss prevents efficient PRC2 and H3K27me3 enrichment on Xist-coated chromatin.","method":"RNA FISH, ChIP-seq, genetic deletion of Jarid2, domain mapping by N-terminal deletion constructs, inducible XCI system","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with genome-wide ChIP-seq, domain mapping, multiple cell systems","pmids":["24462204"],"is_preprint":false},{"year":2011,"finding":"PRC2 in mouse ES cells contains at least three additional subunits beyond HeLa-defined composition: JARID2, MTF2, and esPRC2p48. JARID2, MTF2, and esPRC2p48 together (but not individually) synergistically stimulate PRC2 histone methyltransferase activity in vitro and enhance Oct4/Sox2/Klf4-mediated reprogramming.","method":"Mass spectrometry of PRC2 purified from ES cells, in vitro HMT assay with reconstituted complexes, shRNA knockdown, iPSC reprogramming assay","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution HMT assay, mass spectrometry complex identification, functional reprogramming assay","pmids":["21732481"],"is_preprint":false},{"year":2008,"finding":"Jmj (Jarid2) represses cyclin D1 transcription through a protein complex with histone H3-K9 methyltransferases G9a and GLP; Jmj binds the cyclin D1 promoter and recruits G9a and GLP to increase H3-K9 methylation. Inactivation of both G9a and GLP (but not G9a alone) abolishes Jmj-mediated H3-K9 methylation and cyclin D1 repression.","method":"Co-immunoprecipitation (Jmj-G9a, Jmj-GLP), in vitro HMT assay, ChIP at cyclin D1 promoter, double-knockdown epistasis (G9a and GLP)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — Co-IP, in vitro HMT assay, ChIP, and epistasis experiment in single study","pmids":["19010785"],"is_preprint":false},{"year":2012,"finding":"Drosophila Jarid2 physically associates with all canonical PRC2 components (conserved with mammals), and loss-of-function of Jarid2 in flies selectively affects H3K27 methylation (among several histone modifications tested) without affecting other marks, confirming Jarid2 as a conserved PRC2 interactor that specifically regulates H3K27me3.","method":"Affinity purification of Drosophila Jarid2 and mass spectrometry, genetic mutant analysis with histone modification antibodies, genome-wide ChIP-seq (Jarid2, Su(z)12, H3K27me3)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — biochemical purification + mass spectrometry, genetic mutants, genome-wide ChIP-seq","pmids":["22354997"],"is_preprint":false},{"year":2019,"finding":"JARID2 overrides geometrically defined preferences of core PRC2 for propagating H3K27 methylation on designer chromatin substrates and promotes de novo deposition of H3K27me3. Phosphorylation of JARID2 can partially regulate its ability to stimulate PRC2 activity.","method":"In vitro HMT assays with designer chromatin substrates (semisynthetic nucleosome arrays), phosphorylation assays","journal":"Journal of the American Chemical Society","confidence":"High","confidence_rationale":"Tier 1 / Moderate — rigorous in vitro reconstitution with designer substrates, single lab","pmids":["31479253"],"is_preprint":false},{"year":2011,"finding":"Endothelial-specific deletion of Jarid2 (using Cre-loxP) recapitulates cardiac hypertrabeculation and ventricular noncompaction observed in whole-body Jarid2 knockouts; Jarid2 occupies the Notch1 genomic locus (ChIP) and its deletion leads to increased endocardial Notch1 expression and downstream Notch signaling.","method":"Conditional knockout (tissue-specific Cre-loxP), microarray, quantitative ChIP at Notch1 locus, Notch signaling pathway analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional genetic knockout with specific cellular phenotype and direct ChIP evidence at target locus","pmids":["21402699"],"is_preprint":false},{"year":2011,"finding":"Jarid2 interacts with SETDB1 (a H3K9 methyltransferase) as identified by yeast two-hybrid and confirmed by co-immunoprecipitation; Jarid2 deletion reduces H3K9 methylation at the Notch1 locus in embryonic hearts and reduces SETDB1 accumulation at sites of Jarid2 occupancy.","method":"Yeast two-hybrid screen, co-immunoprecipitation, ChIP at Notch1 locus in KO vs. WT hearts, genome-wide ChIP-chip for H3K9me targets","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid confirmed by Co-IP, ChIP in genetic KO cardiac tissue","pmids":["22110129"],"is_preprint":false},{"year":2013,"finding":"IFN-γ/CIITA signaling induces sequential recruitment of JARID2 and then PRC2 to muscle gene promoters; CIITA first interacts with JARID2, causing RNA Pol II (Ser5-phosphorylated) to pause, then additional PRC2 subunits including EZH2 are recruited in a JARID2-dependent manner, concurrent with H3K27 methylation and repression of myogenic genes.","method":"Co-immunoprecipitation (CIITA-JARID2), ChIP (sequential recruitment), gene expression analysis, JARID2-dependent rescue experiments","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, ChIP for sequential recruitment, JARID2-dependency established by knockdown","pmids":["24327761"],"is_preprint":false},{"year":2014,"finding":"Jarid2 is upregulated by TCR signaling and during positive selection in the thymus; Jarid2 binds the Zbtb16 (PLZF) locus and its loss increases PLZF expression with decreased H3K9me3 at this locus, controlling iNKT cell maturation. Jarid2 is reported as a component of three lysine methyltransferase complexes: PRC2 (H3K27), GLP-G9a (H3K9), and SETDB1 (H3K9).","method":"ChIP at Zbtb16/PLZF locus, genetic knockout (T cell-specific), flow cytometry, H3K9me3 and H3K27me3 ChIP","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and genetic KO with defined phenotype, single lab, complex membership claim for GLP-G9a and SETDB1 inferred from prior literature rather than direct biochemical reconstitution in this paper","pmids":["25105474"],"is_preprint":false},{"year":2011,"finding":"Deletion of Jarid2 in mouse epidermis reduces proliferation and potentiates differentiation of postnatal epidermal progenitors; Jarid2 deficiency reduces H3K27me3 at PRC2-target epidermal differentiation genes in neonatal epidermis, and causes delayed hair follicle cycling due to decreased proliferation of HF stem cells.","method":"Conditional knockout (epidermis-specific), H3K27me3 ChIP, BrdU proliferation assay, histological analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional genetic KO with H3K27me3 ChIP confirming mechanistic link to PRC2 activity","pmids":["21811233"],"is_preprint":false},{"year":2013,"finding":"JARID2 is a direct transcriptional target of the PAX3-FOXO1 fusion protein; JARID2 silencing induces myogenic differentiation (increased MYOG, MYL1 expression); JARID2 binds the MYOG and MYL1 promoters and alters H3K27me3 there in an EED-dependent manner.","method":"ChIP at MYOG/MYL1 promoters, luciferase reporter for PAX3-FOXO1 direct targeting, siRNA knockdown, overexpression rescue","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay in RMS cell lines, single lab","pmids":["23435416"],"is_preprint":false},{"year":2011,"finding":"Jarid2-cyclin D1 genetic epistasis in mouse cardiomyocytes: Jmj/cyclin D1 double-mutant mice show that Jmj is required for normal cardiomyocyte differentiation and GATA4 protein expression through repression of cyclin D1. CDK4 (activated by cyclin D1) phosphorylates GATA4 directly, promoting its degradation in cultured cells.","method":"Double-mutant mouse genetics (Jmj/cyclin D1), transgenic overexpression, in vitro kinase assay (CDK4 phosphorylation of GATA4), rescue by exogenous GATA4","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genetic epistasis in vivo, in vitro kinase assay, transgenic rescue","pmids":["21447557"],"is_preprint":false},{"year":2015,"finding":"JARID2 and the PRC2 complex regulate skeletal muscle differentiation by directly repressing the Wnt antagonist SFRP1; depletion of JARID2 causes upregulation of SFRP1, which blocks MYOD and β-catenin nuclear translocation required for differentiation. ChIP confirmed JARID2 and EZH2 occupancy and H3K27me3 at the SFRP1 locus.","method":"ChIP-seq, ChIP-PCR (JARID2, EZH2, H3K27me3 at SFRP1), shRNA depletion, Wnt pathway rescue (β-catenin nuclear translocation), ectopic SFRP1 expression","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq combined with genetic depletion and functional pathway rescue, direct target identification","pmids":["30119689"],"is_preprint":false},{"year":2019,"finding":"JARID2 and the PRC2 complex regulate the skeletal muscle cell cycle by directly repressing cyclin D1 and cyclin E1 (targets of PRC2-mediated H3K27me3) and repressing RB1; depletion of JARID2 increases proliferation and S-phase accumulation. Ectopic RB1 expression can suppress cyclin D1 in JARID2-depleted cells.","method":"ChIP at cyclin D1, cyclin E1, and RB1 promoters; shRNA stable depletion; flow cytometry cell cycle analysis; ectopic expression rescue","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and genetic depletion with cell cycle readout, single lab","pmids":["31578284"],"is_preprint":false},{"year":2007,"finding":"Jarid2 physically and functionally interacts with zinc finger protein Zfp496 (identified by yeast two-hybrid); Zfp496 functions as a transcriptional activator and inhibits Jarid2-mediated transcriptional repression, while Jarid2 represses Zfp496-mediated transcriptional activation.","method":"Yeast two-hybrid screening, co-immunoprecipitation, transcriptional reporter assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — yeast two-hybrid confirmed by Co-IP and reporter assay, single lab","pmids":["17521633"],"is_preprint":false},{"year":2010,"finding":"Nkx2.5 directly regulates Jarid2 expression in second heart field progenitors; Nkx2.5 occupies consensus binding sites in the Jarid2 promoter (ChIP), and Nkx2.5 overexpression down-regulates Jarid2 promoter activity and mRNA levels.","method":"ChIP at Jarid2 promoter in pharyngeal arch cells, promoter-luciferase reporter assay, overexpression","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase reporter, single lab","pmids":["20549724"],"is_preprint":false},{"year":2015,"finding":"Jarid2 inhibition of JARID2 in hematopoietic stem and progenitor cells (HSPCs) enhances competitive transplantation capacity in mice (similar to Suz12 depletion); JARID2 depletion enhances in vitro expansion and in vivo reconstitution of human HSPCs. Gene expression profiling identified common Suz12 and Jarid2 target genes enriched for H3K27me3.","method":"Competitive bone marrow transplantation, shRNA knockdown, human HSPC expansion assay, gene expression profiling, H3K27me3 ChIP","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional in vivo transplantation assay, single lab","pmids":["25645357"],"is_preprint":false},{"year":2015,"finding":"JARID2 promotes iPSC reprogramming by suppressing Arf expression (a known reprogramming barrier); the N-terminal half of JARID2 is sufficient for this promotion. JARID2 physically interacts with ESRRB, SALL4A, and PRDM14, and these JARID2-associated proteins synergistically facilitate iPSC reprogramming in a JARID2-dependent manner. JARID2 also accelerates silencing of retroviral Klf4 transgene and demethylation of the Nanog promoter.","method":"Co-immunoprecipitation (JARID2-ESRRB, JARID2-SALL4A, JARID2-PRDM14), N-terminal deletion mapping, iPSC reprogramming efficiency assay, bisulfite sequencing (Nanog promoter), domain rescue experiments","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and domain mapping combined with functional reprogramming assay, single lab","pmids":["26523946"],"is_preprint":false},{"year":2018,"finding":"In lineage-committed human keratinocytes (unlike ES cells), JARID2 predominantly exists as a novel low-molecular-weight form (ΔN-JARID2) lacking the N-terminal PRC2-interacting domain, generated by proteolytic cleavage. ΔN-JARID2 (lacking PRC2 interaction) can rescue repression of epidermal differentiation genes in JARID2-null keratinocytes, suggesting a PRC2-independent function in promoting differentiation gene activation.","method":"Western blotting (size determination), JARID2 knockout (keratinocytes), rescue by ΔN-JARID2 expression, RNA-seq of JARID2-null cells","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with rescue by domain-deletion construct, single lab","pmids":["30573669"],"is_preprint":false},{"year":2015,"finding":"Jarid2-deficient ES cells express constitutively high levels of Nanog and reduced PCP signaling components (Wnt9a, Prickle1, Fzd2) and lowered β-catenin activity; depletion of Wnt9a/Prickle1/Fzd2 or overexpression of Nanog phenocopies Jarid2-deficient differentiation block. Co-culture of Jarid2-/- with wild-type ESCs restores variable Nanog expression and β-catenin activity.","method":"Genetic knockout, gene expression profiling, Nanog overexpression rescue, co-culture experiments, blastocyst injection","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic approaches and co-culture rescue, single lab","pmids":["26190104"],"is_preprint":false},{"year":2014,"finding":"JARID2 is involved in TGF-β-induced epithelial-mesenchymal transition; ChIP assays showed JARID2 is recruited to CDH1 and miR-200 family gene regulatory regions during TGF-β treatment, where it regulates H3K27me3 levels and EZH2 occupancy to mediate transcriptional repression of these EMT-suppressor genes.","method":"ChIP (JARID2, EZH2, H3K27me3 at CDH1 and miR-200 loci), siRNA knockdown, TGF-β treatment, gene expression analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP at specific target loci, genetic depletion with pathway phenotype, single lab","pmids":["25542019"],"is_preprint":false},{"year":2016,"finding":"JARID2 promotes HCC invasion and metastasis by repressing PTEN expression through increasing H3K27me3 at the PTEN promoter, which activates AKT and enhances EMT.","method":"ChIP at PTEN promoter (H3K27me3), siRNA knockdown and overexpression, in vitro invasion/migration assays, xenograft metastasis model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP at target locus combined with functional invasion assay, single lab","pmids":["27259236"],"is_preprint":false},{"year":2015,"finding":"JARID2 negatively regulates CCND1 (cyclin D1) expression in leukemia cells by increasing H3K27 trimethylation at the CCND1 promoter; knockdown of JARID2 promotes G1/S transition and proliferation, while ectopic JARID2 expression inhibits these phenotypes.","method":"ChIP (JARID2 and H3K27me3 at CCND1 promoter), siRNA knockdown, ectopic overexpression, flow cytometry cell cycle analysis","journal":"International journal of hematology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP at target locus, gain- and loss-of-function, single lab","pmids":["25939703"],"is_preprint":false},{"year":2017,"finding":"Jarid2 is required for late-stage differentiation of embryonic pancreatic β-cells; conditional ablation in pancreatic progenitors reduces endocrine cell area and impairs β-cell differentiation program. Jarid2-deficient pancreases show impaired deposition of RNAPII-Ser5P (initiating Pol II) but no changes in H3K27me3 at affected endocrine gene promoters, indicating a PRC2-independent mechanism.","method":"Conditional knockout (pancreas-specific Cre), genome-wide expression analysis, ChIP (H3K27me3 and RNAPII-Ser5P at endocrine gene promoters)","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with ChIP evidence for PRC2-independent mechanism, single lab","pmids":["28912479"],"is_preprint":false},{"year":2023,"finding":"Jarid2 regulates the transition from early to late retinal progenitor competence by maintaining H3K27me3 repression of Foxp1; loss of Jarid2 reduces H3K27me3 on Foxp1 and other early progenitor genes, leading to extended production of early-born cell types. Foxp1 is required for extending early retinal cell production after Jarid2 loss (genetic epistasis).","method":"Conditional knockout (retinal progenitor), ChIP (H3K27me3 at Foxp1 and early progenitor gene loci), genetic epistasis (Jarid2/Foxp1 double manipulation), birthdating assays","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP at target loci, genetic epistasis with two-gene manipulation, single lab","pmids":["36924502"],"is_preprint":false},{"year":2019,"finding":"Jarid2 mediates H3K27me3-dependent repression of p16 in bladder cancer tumor-initiating cells; knockdown of Jarid2 upregulates p16 with increased H3K27me3 at the p16 promoter region, and reduces sphere-forming capacity and tumorigenicity of bladder cancer TICs in vivo.","method":"ChIP at p16 promoter, siRNA knockdown, sphere formation assay, in vivo tumorigenicity assay","journal":"Life sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single ChIP assay and single lab; note finding is somewhat contradictory (knockdown of Jarid2 increases H3K27me3 at p16 which is mechanistically inconsistent; likely a reporting issue)","pmids":["31125562"],"is_preprint":false},{"year":2019,"finding":"Myocardial-specific ablation of Jarid2 (αMHC::Cre) causes dilated cardiomyopathy and premature death; Jarid2 is required to repress fetal contractile genes (Tnni1, Acta2) in neonatal stages through ErbB4 signaling, and its loss prevents normal induction of adult contractile gene expression.","method":"Conditional knockout (αMHC-Cre), gene expression profiling, pathway analysis, ErbB4 signaling analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional cardiac-specific KO with defined DCM phenotype and gene expression pathway analysis, single lab","pmids":["30700554"],"is_preprint":false},{"year":2018,"finding":"Deletion of Jarid2 by Nkx2.5-Cre (cardiac progenitors) causes ventricular septal defects, thin myocardium, hypertrabeculation, and neonatal lethality; Jarid2 is required for PRC2 occupancy and H3K27me3 at the Isl1 promoter in the myocardium, and its deletion elevates Isl1, Bmp10, and neural gene expression.","method":"Conditional knockout (Nkx2.5-Cre), ChIP (H3K27me3 and PRC2 at Isl1 promoter), genome-wide ChIP-seq, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with target-specific ChIP evidence, genome-wide analysis, single lab","pmids":["29891551"],"is_preprint":false},{"year":2025,"finding":"JARID2 knockdown in mouse multipotent progenitors enhances T-cell output (distinct from EZH2 loss which increases myeloid differentiation), suggesting JARID2 has PRC2-independent functions in hematopoiesis; mechanistically, JARID2 knockdown in human UCB HSPCs promotes a quiescent long-term self-renewal gene expression program via upregulation of STAT1 and MHC class II immunophenotype, conferring HSC-like potential to human MPPs in vivo.","method":"Genetic comparison of Jarid2 vs. Ezh2 conditional KO, single-cell transcriptomics, competitive transplantation, human HSPC functional assays in vivo","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-cell transcriptomics combined with functional in vivo transplantation, preprint not yet peer-reviewed","pmids":["40791535"],"is_preprint":true},{"year":2016,"finding":"In Drosophila spermatogenesis, dJmj (Jarid2) localizes exclusively to the nucleolus at late growth stage in a Polycomb-dependent manner; Polycomb (Pc) interacts with dJmj at the nucleolus (confirmed by Proximity Ligation Assay), and tTAF is responsible for Pc-mediated recruitment of dJmj to the nucleolus. H3K27me3 levels decrease in nuclei at this stage, correlating with nucleolar sequestration of dJmj.","method":"Immunocytochemistry, Duolink In Situ Proximity Ligation Assay (Pc-dJmj interaction), PcG mutant analysis, tTAF mutant analysis","journal":"Spermatogenesis","confidence":"Low","confidence_rationale":"Tier 3 / Weak — localization study with PLA interaction assay, single lab, Drosophila model, limited functional follow-up","pmids":["28144496"],"is_preprint":false},{"year":2023,"finding":"JARID2 physically interacts with the NuRD complex (identified by immunoaffinity purification and silver staining mass spectrometry, confirmed by Co-IP and GST pull-down) in breast cancer cells; JARID2-NuRD co-occupies and represses tumor suppressor genes BRCA2, RB1, and INPP4B (confirmed by ChIP-seq and ChIP-reChIP assays).","method":"Immunoaffinity purification + mass spectrometry, Co-IP, GST pull-down, ChIP-seq, ChIP-PCR, ChIP-reChIP","journal":"Cancer communications (London, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical methods (MS, Co-IP, GST pull-down, ChIP-seq), single lab","pmids":["37658635"],"is_preprint":false}],"current_model":"JARID2 is a catalytically inactive, multifunctional regulatory subunit of Polycomb Repressive Complex 2 (PRC2) that promotes PRC2 recruitment to target chromatin—via recognition of H2AK119ub1 through its N-terminal ubiquitin interaction motif and via lncRNA-mediated bridging—while simultaneously acting as a substrate for PRC2-mediated methylation; this JARID2 methylation is recognized by EED and allosterically activates PRC2, creating a positive feedback loop for H3K27me3 deposition. In a context-dependent manner, JARID2 also associates with H3K9 methyltransferases (G9a/GLP, SETDB1, SETDB1) to repress target genes such as cyclin D1 and Notch1, and in lineage-committed cells exists as a cleaved N-terminally truncated form that functions independently of PRC2 to promote differentiation gene activation."},"narrative":{"mechanistic_narrative":"JARID2 is a chromatin-associated regulatory subunit of Polycomb Repressive Complex 2 (PRC2) that calibrates the genomic targeting and enzymatic output of H3K27me3 deposition at developmental genes [PMID:20075857, PMID:20064375]. It is a stable PRC2 component required for the bulk of PRC2 occupancy across PcG target genes and is sufficient to recruit PRC2 to a heterologous promoter, with its loss collapsing PRC2 binding and H3K27me3 [PMID:20075857]. JARID2 directs PRC2 to chromatin through multiple recruitment modes: an N-terminal ubiquitin interaction motif that binds H2AK119ub1 to couple PRC1 and PRC2 activities [PMID:27892467], and a discrete RNA-binding region that engages long noncoding RNAs—including Meg3 and Xist—to bridge PRC2 to target loci and to the inactive X chromosome [PMID:24374312, PMID:24462204]. Beyond recruitment, JARID2 is itself a PRC2 substrate: EZH2-mediated methylation of JARID2 is read by EED and allosterically activates PRC2, and structural work shows methylated JARID2 mimics a methylated H3 tail while contacting both EED and H2AK119-ubiquitin to stimulate methyltransferase activity, enabling de novo H3K27me3 deposition even on substrates that disfavor core PRC2 [PMID:25620564, PMID:29348366, PMID:33479123, PMID:31479253]. Through these activities JARID2 governs cell-fate decisions in ES cells, cardiac and endothelial development, epidermal and skeletal-muscle differentiation, and hematopoiesis, frequently by PRC2-dependent repression of specific targets such as Notch1, Isl1, cyclin D1, SFRP1, and PTEN [PMID:21402699, PMID:21811233, PMID:30119689, PMID:31578284, PMID:27259236, PMID:29891551]. In a context-dependent manner JARID2 also acts outside canonical PRC2: it partners with the H3K9 methyltransferases G9a/GLP and SETDB1 to repress cyclin D1 and Notch1 [PMID:19010785, PMID:22110129], associates with the NuRD complex to silence tumor-suppressor genes [PMID:37658635], and in lineage-committed keratinocytes exists as an N-terminally cleaved form (ΔN-JARID2) lacking the PRC2-interacting domain that promotes differentiation-gene activation independently of PRC2 [PMID:30573669].","teleology":[{"year":2008,"claim":"Before its PRC2 role was known, JARID2 (Jmj) was shown to act as a transcriptional repressor by templating H3K9 methylation, establishing it as a chromatin-modifying scaffold rather than an independent enzyme.","evidence":"Co-IP, in vitro HMT assay, ChIP, and G9a/GLP double-knockdown epistasis at the cyclin D1 promoter","pmids":["19010785"],"confidence":"High","gaps":["Did not establish JARID2's relationship to PRC2 or H3K27 methylation","Mechanism of JARID2 recruitment to the cyclin D1 promoter not defined"]},{"year":2009,"claim":"JARID2 was defined as a bona fide PRC2 subunit that simultaneously promotes PRC2 recruitment yet inhibits its in vitro activity, framing it as a 'molecular rheostat' for developmental gene regulation.","evidence":"Co-IP, genome-wide ChIP-seq of Jarid2/Ezh2/Suz12, in vitro HMT assay ± Jarid2, Xenopus knockdown","pmids":["20064375"],"confidence":"High","gaps":["The apparent in vitro inhibition versus in vivo recruitment paradox unresolved","No structural basis for the activity modulation"]},{"year":2010,"claim":"Multiple studies established that JARID2 is genome-wide required for PRC2 occupancy and for co-recruitment of PRC1 and paused RNA Pol II, defining it as the principal targeting determinant of PRC2 in ES cells.","evidence":"Reciprocal Co-IP, genome-wide ChIP-seq, heterologous promoter recruitment assay, Jarid2-null ES cells with chromatin profiling","pmids":["20075857","20473294"],"confidence":"High","gaps":["Molecular mechanism by which JARID2 selects target loci not yet defined","Did not explain how recruitment is coupled to enzymatic activation"]},{"year":2011,"claim":"JARID2 was shown to be a conserved PRC2 cofactor whose loss specifically affects H3K27me3, and to synergize with MTF2 and esPRC2p48 to stimulate PRC2 activity and reprogramming, beginning to reconcile its dual recruitment/activity roles.","evidence":"Mass spectrometry of ES-cell PRC2, reconstituted in vitro HMT assays, Drosophila genetic mutants and ChIP-seq, iPSC reprogramming assay","pmids":["21732481","22354997"],"confidence":"High","gaps":["How cofactor combinations physically reorganize PRC2 not yet shown","Did not identify the chromatin signal driving JARID2-dependent targeting"]},{"year":2011,"claim":"Tissue-specific deletions revealed that JARID2 controls discrete differentiation programs by direct repression of lineage genes, linking its molecular activity to organ development.","evidence":"Conditional Cre-loxP knockouts in endothelium and epidermis, ChIP at Notch1 and differentiation loci, H3K27me3 ChIP, proliferation assays","pmids":["21402699","21811233","22110129"],"confidence":"High","gaps":["Whether cardiac repression operates through PRC2 or H3K9 routes was not fully separated","Recruitment specificity to Notch1 versus other loci not defined"]},{"year":2013,"claim":"Identification of a 30-aa lncRNA-binding region showed that noncoding RNAs (e.g., Meg3) stimulate JARID2-EZH2 interaction and PRC2 recruitment, providing one mechanism for locus-specific targeting.","evidence":"Native and cross-linked RIP, in vitro JARID2-EZH2 interaction ± lncRNA, ChIP in MEG3-null cells","pmids":["24374312"],"confidence":"High","gaps":["Sequence/structural determinants of RNA selectivity not defined","How RNA binding is coordinated with histone-mark reading unknown"]},{"year":2014,"claim":"JARID2 was identified as the mediator of Xist-induced PRC2 targeting to the inactive X, demonstrating RNA-guided, PRC2-independent recruitment chromosome-wide.","evidence":"RNA FISH, ChIP-seq, Jarid2 deletion, N-terminal domain mapping in an inducible XCI system","pmids":["24462204"],"confidence":"High","gaps":["Direct Xist-JARID2 contact not biochemically resolved","How Xist repeats engage the N-terminal domain structurally unknown"]},{"year":2015,"claim":"JARID2 was shown to be methylated by EZH2 and read by EED, allosterically activating PRC2—resolving the recruitment-versus-activity paradox by revealing a positive feedback loop seeding H3K27me3 de novo.","evidence":"In vitro methylation, mass spectrometry site identification, EED binding and allosteric activation assays, differentiation H3K27me3 ChIP","pmids":["25620564"],"confidence":"High","gaps":["Kinetics of methylation versus recruitment in vivo not measured","How the feedback loop is restricted to correct loci unclear"]},{"year":2016,"claim":"A ubiquitin interaction motif was found to bind H2AK119ub1, defining a direct chromatin-mark-reading mechanism that couples PRC1-deposited ubiquitin to PRC2 localization.","evidence":"Sequence-based UIM identification, in vitro ubiquitin binding, Co-IP, ChIP under H2AK119ub1 manipulation, UIM mutagenesis","pmids":["27892467"],"confidence":"High","gaps":["Relative contribution of UIM versus lncRNA recruitment in vivo not quantified","Structural geometry of UIM-ubiquitin engagement not yet shown"]},{"year":2018,"claim":"Cryo-EM structures provided the physical basis for JARID2 stimulation of PRC2, showing methylated JARID2 mimics a methyl-H3 tail and stabilizes the active complex with AEBP2.","evidence":"Cryo-EM of human PRC2 with JARID2 and AEBP2, functional validation of cofactor interactions","pmids":["29348366"],"confidence":"High","gaps":["Structure lacked a nucleosome substrate","Did not resolve the H2AK119ub1-bound configuration"]},{"year":2021,"claim":"A nucleosome-bound cryo-EM structure unified the recruitment and activation mechanisms, showing JARID2 contacts both EED and H2AK119-ubiquitin and helps overcome inhibitory active marks.","evidence":"Cryo-EM with designer H2AK119ub1 nucleosomes, in vitro PRC2 activity assays","pmids":["33479123","31479253"],"confidence":"High","gaps":["In vivo relevance of overriding H3K4me3/H3K36me3 inhibition not directly tested","Role of JARID2 phosphorylation in this geometry not structurally resolved"]},{"year":2018,"claim":"JARID2 was shown to act through non-PRC2 routes—partnering with NuRD and existing as a cleaved ΔN-JARID2 in committed cells—revealing that its function is context-dependent and not strictly PRC2-bound.","evidence":"Western blot size determination, keratinocyte knockout with ΔN-JARID2 rescue, RNA-seq; immunoaffinity MS, Co-IP, GST pull-down, ChIP-reChIP for NuRD","pmids":["30573669","37658635"],"confidence":"Medium","gaps":["Protease generating ΔN-JARID2 not identified","How ΔN-JARID2 activates differentiation genes mechanistically unknown"]},{"year":2025,"claim":"Comparison of Jarid2 versus Ezh2 loss in hematopoietic progenitors indicated PRC2-independent control of self-renewal and lineage output, distinguishing JARID2's regulatory roles from core PRC2.","evidence":"Conditional KO comparison, single-cell transcriptomics, competitive transplantation, human HSPC assays (preprint)","pmids":["40791535"],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","Molecular basis of STAT1/MHC-II upregulation by JARID2 loss not defined"]},{"year":null,"claim":"How JARID2's distinct recruitment modes (H2AK119ub1, lncRNA, sequence-specific factors) and its PRC2-independent partnerships (G9a/GLP, SETDB1, NuRD, ΔN-JARID2) are selected and balanced across cell types remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating ubiquitin-reading, RNA-bridging, and methylation feedback at single loci","Determinants switching JARID2 between PRC2 and H3K9/NuRD complexes unknown","Identity and regulation of the ΔN-JARID2 cleavage event undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[3,5]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[7,8]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[10,22]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,4,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[4,8]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,3,4]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[10,20,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[13,17,20,35]}],"complexes":["PRC2","G9a/GLP (H3K9 methyltransferase complex)","SETDB1 complex","NuRD"],"partners":["EZH2","SUZ12","EED","AEBP2","G9A","GLP","SETDB1","MTF2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92833","full_name":"Protein Jumonji","aliases":["Jumonji/ARID domain-containing protein 2"],"length_aa":1246,"mass_kda":138.7,"function":"Regulator of histone methyltransferase complexes that plays an essential role in embryonic development, including heart and liver development, neural tube fusion process and hematopoiesis (PubMed:20075857). Acts as an accessory subunit for the core PRC2 (Polycomb repressive complex 2) complex, which mediates histone H3K27 (H3K27me3) trimethylation on chromatin (PubMed:20075857, PubMed:29499137, PubMed:31959557). Binds DNA and mediates the recruitment of the PRC2 complex to target genes in embryonic stem cells, thereby playing a key role in stem cell differentiation and normal embryonic development (PubMed:20075857). In cardiac cells, it is required to repress expression of cyclin-D1 (CCND1) by activating methylation of 'Lys-9' of histone H3 (H3K9me) by the GLP1/EHMT1 and G9a/EHMT2 histone methyltransferases (By similarity). Also acts as a transcriptional repressor of ANF via its interaction with GATA4 and NKX2-5 (By similarity). Participates in the negative regulation of cell proliferation signaling (By similarity). Does not have histone demethylase activity (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q92833/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/JARID2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/JARID2","total_profiled":1310},"omim":[{"mim_id":"620098","title":"DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES; DIDDF","url":"https://www.omim.org/entry/620098"},{"mim_id":"617934","title":"AE-BINDING PROTEIN 2; AEBP2","url":"https://www.omim.org/entry/617934"},{"mim_id":"617795","title":"ELONGIN BC- AND POLYCOMB REPRESSIVE COMPLEX 2-ASSOCIATED PROTEIN; EPOP","url":"https://www.omim.org/entry/617795"},{"mim_id":"613911","title":"ZINC FINGER PROTEIN 496; ZNF496","url":"https://www.omim.org/entry/613911"},{"mim_id":"611799","title":"LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR-LIKE PROTEIN; LCORL","url":"https://www.omim.org/entry/611799"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":54.5}],"url":"https://www.proteinatlas.org/search/JARID2"},"hgnc":{"alias_symbol":[],"prev_symbol":["JMJ"]},"alphafold":{"accession":"Q92833","domains":[{"cath_id":"2.60.120.650","chopping":"560-617_812-1034","consensus_level":"high","plddt":92.7048,"start":560,"end":1034},{"cath_id":"1.10.150.60","chopping":"622-738","consensus_level":"medium","plddt":89.8226,"start":622,"end":738},{"cath_id":"-","chopping":"1050-1112_1136-1201","consensus_level":"high","plddt":89.7626,"start":1050,"end":1201}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92833","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92833-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92833-F1-predicted_aligned_error_v6.png","plddt_mean":61.91},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=JARID2","jax_strain_url":"https://www.jax.org/strain/search?query=JARID2"},"sequence":{"accession":"Q92833","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92833.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92833/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92833"}},"corpus_meta":[{"pmid":"20075857","id":"PMC_20075857","title":"JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20075857","citation_count":458,"is_preprint":false},{"pmid":"20064375","id":"PMC_20064375","title":"Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20064375","citation_count":444,"is_preprint":false},{"pmid":"24374312","id":"PMC_24374312","title":"Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin.","date":"2013","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24374312","citation_count":308,"is_preprint":false},{"pmid":"20473294","id":"PMC_20473294","title":"Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators.","date":"2010","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20473294","citation_count":256,"is_preprint":false},{"pmid":"25620564","id":"PMC_25620564","title":"Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25620564","citation_count":226,"is_preprint":false},{"pmid":"27892467","id":"PMC_27892467","title":"Jarid2 binds mono-ubiquitylated H2A lysine 119 to mediate crosstalk between Polycomb complexes PRC1 and PRC2.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27892467","citation_count":223,"is_preprint":false},{"pmid":"24462204","id":"PMC_24462204","title":"Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24462204","citation_count":209,"is_preprint":false},{"pmid":"33479123","id":"PMC_33479123","title":"JARID2 and AEBP2 regulate PRC2 in the presence of H2AK119ub1 and other histone modifications.","date":"2021","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33479123","citation_count":197,"is_preprint":false},{"pmid":"29348366","id":"PMC_29348366","title":"Structures of human PRC2 with its cofactors AEBP2 and JARID2.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29348366","citation_count":168,"is_preprint":false},{"pmid":"21732481","id":"PMC_21732481","title":"PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming.","date":"2011","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/21732481","citation_count":127,"is_preprint":false},{"pmid":"25097177","id":"PMC_25097177","title":"miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25097177","citation_count":105,"is_preprint":false},{"pmid":"22190018","id":"PMC_22190018","title":"Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.","date":"2011","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22190018","citation_count":91,"is_preprint":false},{"pmid":"23435416","id":"PMC_23435416","title":"JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23435416","citation_count":84,"is_preprint":false},{"pmid":"19759154","id":"PMC_19759154","title":"Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival.","date":"2009","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19759154","citation_count":83,"is_preprint":false},{"pmid":"21074441","id":"PMC_21074441","title":"Inactive yet indispensable: the tale of Jarid2.","date":"2010","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21074441","citation_count":78,"is_preprint":false},{"pmid":"19010785","id":"PMC_19010785","title":"A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19010785","citation_count":64,"is_preprint":false},{"pmid":"21811233","id":"PMC_21811233","title":"Jarid2 regulates mouse epidermal stem cell activation and differentiation.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21811233","citation_count":64,"is_preprint":false},{"pmid":"22354997","id":"PMC_22354997","title":"Polycomb repressive complex 2-dependent and -independent functions of Jarid2 in transcriptional regulation in Drosophila.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22354997","citation_count":63,"is_preprint":false},{"pmid":"21402699","id":"PMC_21402699","title":"Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21402699","citation_count":62,"is_preprint":false},{"pmid":"25542019","id":"PMC_25542019","title":"JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25542019","citation_count":60,"is_preprint":false},{"pmid":"22110129","id":"PMC_22110129","title":"Jarid2 (Jumonji, AT rich interactive domain 2) regulates NOTCH1 expression via histone modification in the developing heart.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22110129","citation_count":59,"is_preprint":false},{"pmid":"30783079","id":"PMC_30783079","title":"Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl.","date":"2019","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/30783079","citation_count":59,"is_preprint":false},{"pmid":"32135463","id":"PMC_32135463","title":"miR-155 antagomir protect against DSS-induced colitis in mice through regulating Th17/Treg cell balance by Jarid2/Wnt/β-catenin.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32135463","citation_count":53,"is_preprint":false},{"pmid":"20439426","id":"PMC_20439426","title":"The JARID2-PRC2 duality.","date":"2010","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20439426","citation_count":52,"is_preprint":false},{"pmid":"26298346","id":"PMC_26298346","title":"miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2.","date":"2015","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26298346","citation_count":48,"is_preprint":false},{"pmid":"21447557","id":"PMC_21447557","title":"Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21447557","citation_count":47,"is_preprint":false},{"pmid":"25645357","id":"PMC_25645357","title":"Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25645357","citation_count":47,"is_preprint":false},{"pmid":"26190104","id":"PMC_26190104","title":"Jarid2 Coordinates Nanog Expression and PCP/Wnt Signaling Required for Efficient ESC Differentiation and Early Embryo Development.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26190104","citation_count":46,"is_preprint":false},{"pmid":"27259236","id":"PMC_27259236","title":"JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27259236","citation_count":41,"is_preprint":false},{"pmid":"20549724","id":"PMC_20549724","title":"Jarid2 is among a set of genes differentially regulated by Nkx2.5 during outflow tract morphogenesis.","date":"2010","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/20549724","citation_count":40,"is_preprint":false},{"pmid":"24327761","id":"PMC_24327761","title":"Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.","date":"2013","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/24327761","citation_count":38,"is_preprint":false},{"pmid":"25105474","id":"PMC_25105474","title":"Jarid2 is induced by TCR signalling and controls iNKT cell maturation.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25105474","citation_count":36,"is_preprint":false},{"pmid":"22681640","id":"PMC_22681640","title":"Immune function genes CD99L2, JARID2 and TPO show association with autism spectrum disorder.","date":"2012","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/22681640","citation_count":34,"is_preprint":false},{"pmid":"19884986","id":"PMC_19884986","title":"Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia.","date":"2009","source":"Journal of biomedicine & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/19884986","citation_count":32,"is_preprint":false},{"pmid":"34974799","id":"PMC_34974799","title":"Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis.","date":"2022","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/34974799","citation_count":31,"is_preprint":false},{"pmid":"30119689","id":"PMC_30119689","title":"JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling.","date":"2018","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/30119689","citation_count":30,"is_preprint":false},{"pmid":"16967465","id":"PMC_16967465","title":"Positive association of schizophrenia to JARID2 gene.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16967465","citation_count":29,"is_preprint":false},{"pmid":"36924502","id":"PMC_36924502","title":"Jarid2 promotes temporal progression of retinal progenitors via repression of Foxp1.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36924502","citation_count":28,"is_preprint":false},{"pmid":"25939703","id":"PMC_25939703","title":"JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.","date":"2015","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/25939703","citation_count":28,"is_preprint":false},{"pmid":"29891551","id":"PMC_29891551","title":"Cardiac-specific developmental and epigenetic functions of Jarid2 during embryonic development.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29891551","citation_count":27,"is_preprint":false},{"pmid":"25224965","id":"PMC_25224965","title":"Temperature influences histone methylation and mRNA expression of the Jmj-C histone-demethylase orthologues during the early development of the oyster Crassostrea gigas.","date":"2014","source":"Marine genomics","url":"https://pubmed.ncbi.nlm.nih.gov/25224965","citation_count":27,"is_preprint":false},{"pmid":"17521633","id":"PMC_17521633","title":"Characterization of zinc finger protein 496 that interacts with Jumonji/Jarid2.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17521633","citation_count":26,"is_preprint":false},{"pmid":"31578284","id":"PMC_31578284","title":"JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31578284","citation_count":25,"is_preprint":false},{"pmid":"30573669","id":"PMC_30573669","title":"A novel form of JARID2 is required for differentiation in lineage-committed cells.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/30573669","citation_count":25,"is_preprint":false},{"pmid":"31125562","id":"PMC_31125562","title":"Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.","date":"2019","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31125562","citation_count":24,"is_preprint":false},{"pmid":"31479253","id":"PMC_31479253","title":"Nucleation and Propagation of Heterochromatin by the Histone Methyltransferase PRC2: Geometric Constraints and Impact of the Regulatory Subunit JARID2.","date":"2019","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/31479253","citation_count":23,"is_preprint":false},{"pmid":"23294540","id":"PMC_23294540","title":"Haploinsufficiency of two histone modifier genes on 6p22.3, ATXN1 and JARID2, is associated with intellectual disability.","date":"2013","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23294540","citation_count":23,"is_preprint":false},{"pmid":"33077894","id":"PMC_33077894","title":"JARID2 haploinsufficiency is associated with a clinically distinct neurodevelopmental syndrome.","date":"2020","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33077894","citation_count":22,"is_preprint":false},{"pmid":"35173309","id":"PMC_35173309","title":"LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35173309","citation_count":22,"is_preprint":false},{"pmid":"33257231","id":"PMC_33257231","title":"Genome-wide analysis of JMJ-C histone demethylase family involved in salt-tolerance in Gossypium hirsutum L.","date":"2020","source":"Plant physiology and biochemistry : PPB","url":"https://pubmed.ncbi.nlm.nih.gov/33257231","citation_count":21,"is_preprint":false},{"pmid":"27328068","id":"PMC_27328068","title":"Brazilian multicenter study of association between polymorphisms in CRISPLD2 and JARID2 and non-syndromic oral clefts.","date":"2016","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27328068","citation_count":20,"is_preprint":false},{"pmid":"26523946","id":"PMC_26523946","title":"Combined Overexpression of JARID2, PRDM14, ESRRB, and SALL4A Dramatically Improves Efficiency and Kinetics of Reprogramming to Induced Pluripotent Stem Cells.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/26523946","citation_count":20,"is_preprint":false},{"pmid":"24830456","id":"PMC_24830456","title":"RETRACTED: The downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 axis and by human cytomegalovirus (HCMV) associated factors allows the activation of the HCMV major IE promoter and the transition to productive infection.","date":"2014","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/24830456","citation_count":20,"is_preprint":false},{"pmid":"37658635","id":"PMC_37658635","title":"JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin.","date":"2023","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37658635","citation_count":19,"is_preprint":false},{"pmid":"28765957","id":"PMC_28765957","title":"Knockdown of JARID2 inhibits the proliferation and invasion of ovarian cancer through the PI3K/Akt signaling pathway.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28765957","citation_count":19,"is_preprint":false},{"pmid":"18805276","id":"PMC_18805276","title":"Induction by left ventricular overload and left ventricular failure of the human Jumonji gene (JARID2) encoding a protein that regulates transcription and reexpression of a protective fetal program.","date":"2008","source":"The Journal of thoracic and cardiovascular surgery","url":"https://pubmed.ncbi.nlm.nih.gov/18805276","citation_count":19,"is_preprint":false},{"pmid":"24406622","id":"PMC_24406622","title":"The Jumonji gene family in Crassostrea gigas suggests evolutionary conservation of Jmj-C histone demethylases orthologues in the oyster gametogenesis and development.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24406622","citation_count":18,"is_preprint":false},{"pmid":"29232705","id":"PMC_29232705","title":"Etv2-miR-130a-Jarid2 cascade regulates vascular patterning during embryogenesis.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29232705","citation_count":17,"is_preprint":false},{"pmid":"20506229","id":"PMC_20506229","title":"Expression and association data strongly support JARID2 involvement in nonsyndromic cleft lip with or without cleft palate.","date":"2010","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/20506229","citation_count":17,"is_preprint":false},{"pmid":"28445934","id":"PMC_28445934","title":"Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28445934","citation_count":16,"is_preprint":false},{"pmid":"37353042","id":"PMC_37353042","title":"JARID2 and EZH2, the eminent epigenetic drivers in human cancer.","date":"2023","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/37353042","citation_count":15,"is_preprint":false},{"pmid":"30253332","id":"PMC_30253332","title":"MiR-155 inhibition ameliorates 2, 4, 6-Trinitrobenzenesulfonic acid (TNBS)-induced experimental colitis in rat via influencing the differentiation of Th17 cells by Jarid2.","date":"2018","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30253332","citation_count":15,"is_preprint":false},{"pmid":"35887345","id":"PMC_35887345","title":"DNA Methylation Signature for JARID2-Neurodevelopmental Syndrome.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35887345","citation_count":14,"is_preprint":false},{"pmid":"34246759","id":"PMC_34246759","title":"JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1.","date":"2021","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/34246759","citation_count":14,"is_preprint":false},{"pmid":"29302400","id":"PMC_29302400","title":"Function of JARID2 in bovines during early embryonic development.","date":"2017","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/29302400","citation_count":14,"is_preprint":false},{"pmid":"28912479","id":"PMC_28912479","title":"Late-stage differentiation of embryonic pancreatic β-cells requires Jarid2.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28912479","citation_count":14,"is_preprint":false},{"pmid":"29466914","id":"PMC_29466914","title":"Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal.","date":"2018","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/29466914","citation_count":12,"is_preprint":false},{"pmid":"36471281","id":"PMC_36471281","title":"The LINC00852/miR-29a-3p/JARID2 axis regulates the proliferation and invasion of prostate cancer cell.","date":"2022","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36471281","citation_count":11,"is_preprint":false},{"pmid":"34094675","id":"PMC_34094675","title":"MiR-22 regulated T cell differentiation and hepatocellular carcinoma growth by directly targeting Jarid2.","date":"2021","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34094675","citation_count":9,"is_preprint":false},{"pmid":"34251962","id":"PMC_34251962","title":"The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ).","date":"2021","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34251962","citation_count":9,"is_preprint":false},{"pmid":"38093236","id":"PMC_38093236","title":"Genome-wide identification and expression analysis of the JMJ-C gene family in melon (Cucumis melo L.) reveals their potential role in fruit development.","date":"2023","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38093236","citation_count":8,"is_preprint":false},{"pmid":"36640627","id":"PMC_36640627","title":"JARID2 regulates epithelial mesenchymal transition through the PTEN/AKT signalling pathways in ovarian endometriosis.","date":"2023","source":"Reproductive biology","url":"https://pubmed.ncbi.nlm.nih.gov/36640627","citation_count":8,"is_preprint":false},{"pmid":"33789312","id":"PMC_33789312","title":"LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2.","date":"2021","source":"Urologia internationalis","url":"https://pubmed.ncbi.nlm.nih.gov/33789312","citation_count":8,"is_preprint":false},{"pmid":"27641964","id":"PMC_27641964","title":"Reduced Expression of Jumonji AT-Rich Interactive Domain 2 (JARID2) in Glioma Inhibits Tumor Growth In Vitro and In Vivo.","date":"2016","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/27641964","citation_count":8,"is_preprint":false},{"pmid":"37762546","id":"PMC_37762546","title":"Functional Insight into and Refinement of the Genomic Boundaries of the JARID2-Neurodevelopmental Disorder Episignature.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37762546","citation_count":7,"is_preprint":false},{"pmid":"28714012","id":"PMC_28714012","title":"Knockdown of JARID2 inhibits the viability and migration of placenta trophoblast cells in preeclampsia.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28714012","citation_count":7,"is_preprint":false},{"pmid":"35533077","id":"PMC_35533077","title":"Phenotypic expansion and variable expressivity in individuals with JARID2-related intellectual disability: A case series.","date":"2022","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35533077","citation_count":7,"is_preprint":false},{"pmid":"30700554","id":"PMC_30700554","title":"Myocardial-specific ablation of Jumonji and AT-rich interaction domain-containing 2 (Jarid2) leads to dilated cardiomyopathy in mice.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30700554","citation_count":6,"is_preprint":false},{"pmid":"32632266","id":"PMC_32632266","title":"Promoting role of circ-Jarid2/miR-129-5p/Celf1 axis in cardiac hypertrophy.","date":"2020","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32632266","citation_count":6,"is_preprint":false},{"pmid":"25155265","id":"PMC_25155265","title":"Association of JARID2 polymorphisms with non-syndromic orofacial clefts in northern Chinese Han population.","date":"2014","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25155265","citation_count":6,"is_preprint":false},{"pmid":"24950205","id":"PMC_24950205","title":"Jarid2 links MicroRNA and chromatin in Th17 cells.","date":"2014","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/24950205","citation_count":6,"is_preprint":false},{"pmid":"38273784","id":"PMC_38273784","title":"Valproic acid regulates the miR-155/Jarid2 axis by affecting miR-155 promoter methylation in glioma.","date":"2024","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/38273784","citation_count":5,"is_preprint":false},{"pmid":"38961353","id":"PMC_38961353","title":"JARID2, a novel regulatory factor, promotes cell proliferation, migration, and invasion in oral squamous cell carcinoma.","date":"2024","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38961353","citation_count":4,"is_preprint":false},{"pmid":"36578923","id":"PMC_36578923","title":"Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36578923","citation_count":4,"is_preprint":false},{"pmid":"39417126","id":"PMC_39417126","title":"Genome-wide scan of Flortaucipir PET levels finds JARID2 associated with cerebral tau deposition.","date":"2024","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39417126","citation_count":3,"is_preprint":false},{"pmid":"39702523","id":"PMC_39702523","title":"The neurodevelopmental regulatory role and clinical value of hsa-circ-CORO1C-hsa-miR-708-3p-JARID2 + LNPEP axis in early-onset schizophrenia.","date":"2024","source":"Schizophrenia (Heidelberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39702523","citation_count":3,"is_preprint":false},{"pmid":"35979655","id":"PMC_35979655","title":"A novel partial de novo duplication of JARID2 gene causing a neurodevelopmental phenotype.","date":"2022","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35979655","citation_count":3,"is_preprint":false},{"pmid":"28144496","id":"PMC_28144496","title":"Polycomb-dependent nucleolus localization of Jumonji/Jarid2 during Drosophila spermatogenesis.","date":"2016","source":"Spermatogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/28144496","citation_count":3,"is_preprint":false},{"pmid":"38203196","id":"PMC_38203196","title":"A Functional Single Nucleotide Polymorphism in the 3' Untranslated Region of the Porcine JARID2 Gene Is Associated with Aggressive Behavior of Weaned Pigs after Mixing.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38203196","citation_count":2,"is_preprint":false},{"pmid":"37309591","id":"PMC_37309591","title":"Integrated bioinformatics and experimental validation reveal the role of JARID2 in ovarian cancer.","date":"2023","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/37309591","citation_count":1,"is_preprint":false},{"pmid":"40883266","id":"PMC_40883266","title":"METTL3-mediated m6A modification of circCDKAL1 regulates macrophage M1 polarization and nasal epithelial cell barrier function in allergic rhinitis through IGF2BP2/JARID2/HMGB1 axis.","date":"2025","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/40883266","citation_count":1,"is_preprint":false},{"pmid":"35797377","id":"PMC_35797377","title":"Genetic determination and JARID2 over-expression in a thermal incubation experiment in Casque-Headed Lizard.","date":"2022","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/35797377","citation_count":1,"is_preprint":false},{"pmid":"39254227","id":"PMC_39254227","title":"JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway.","date":"2024","source":"Expert review of anticancer therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39254227","citation_count":1,"is_preprint":false},{"pmid":"38394221","id":"PMC_38394221","title":"MiR-155 promotes compensatory lung growth by inhibiting JARID2 activation of CD34+ endothelial progenitor cells.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/38394221","citation_count":1,"is_preprint":false},{"pmid":"39619816","id":"PMC_39619816","title":"Jumonji and AT-Rich Interacting Domain 2 (JARID2) exhibits a tumor-suppressive role in Oral Squamous Cell Carcinoma by modulating tumor progression and metastasis.","date":"2024","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/39619816","citation_count":1,"is_preprint":false},{"pmid":"39420919","id":"PMC_39420919","title":"Association of HHV‑6 reactivation and SLC6A3 (C>T, rs40184), BDNF (C>T, rs6265), and JARID2 (G>A, rs9383046) single nucleotide polymorphisms in depression.","date":"2024","source":"Biomedical reports","url":"https://pubmed.ncbi.nlm.nih.gov/39420919","citation_count":1,"is_preprint":false},{"pmid":"41794262","id":"PMC_41794262","title":"miR-454-3p drives development of hepatic steatosis by negatively regulating JARID2.","date":"2026","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41794262","citation_count":1,"is_preprint":false},{"pmid":"40791535","id":"PMC_40791535","title":"Functional Comparison to Ezh2 Reveals PRC2-Independent Functions of Jarid2 in Hematopoietic Stem Cell Lineage Commitment.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40791535","citation_count":1,"is_preprint":false},{"pmid":"33126912","id":"PMC_33126912","title":"Autoregulation of JARID2 through PRC2 interaction with its antisense ncRNA.","date":"2020","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/33126912","citation_count":0,"is_preprint":false},{"pmid":"40950155","id":"PMC_40950155","title":"JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow Transplantation.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40950155","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51383,"output_tokens":10067,"usd":0.152577,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20181,"output_tokens":4944,"usd":0.112253,"stage2_stop_reason":"end_turn"},"total_usd":0.26483,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"JARID2 forms a stable complex with PRC2 (containing EZH2, SUZ12, EED) in ES cells, is required for PRC2 binding to >90% of PcG target genes genome-wide, and is sufficient to recruit PcG proteins to a heterologous promoter; inhibition of JARID2 causes major loss of PRC2 binding and reduction of H3K27me3 at target genes.\",\n      \"method\": \"Co-immunoprecipitation, genome-wide ChIP-seq, heterologous promoter recruitment assay, shRNA knockdown with H3K27me3 ChIP\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, genome-wide ChIP-seq, functional recruitment assay, replicated across multiple contemporaneous studies\",\n      \"pmids\": [\"20075857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Jarid2 is a PRC2 subunit in ES cells that promotes PRC2 recruitment to target genes while simultaneously inhibiting PRC2 histone methyltransferase activity in vitro, acting as a 'molecular rheostat' that calibrates PRC2 function at developmental genes.\",\n      \"method\": \"Co-IP to establish PRC2 subunit status, genome-wide ChIP-seq (Jarid2, Ezh2, Suz12), in vitro histone methyltransferase activity assay with and without Jarid2, Xenopus knockdown\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro enzymatic assay combined with genome-wide ChIP-seq and genetic knockdown, replicated across contemporaneous studies\",\n      \"pmids\": [\"20064375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Jarid2 is a novel subunit of PRC2 required for co-recruitment of PRC1 and RNA Polymerase II (Ser5-phosphorylated) to developmental genes in ES cells; Jarid2-deficient ES cells show reduced H3K4me2/me3 and H3K27me3 marking and loss of PRC1/PRC2 occupancy.\",\n      \"method\": \"ChIP-seq, ChIP-PCR, genetic knockout (Jarid2-deficient ES cells), immunofluorescence\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined chromatin phenotype, genome-wide occupancy analysis, replicated across contemporaneous studies\",\n      \"pmids\": [\"20473294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"JARID2 is methylated by PRC2 (EZH2); this methylation is recognized by the EED subunit of PRC2 and triggers allosteric activation of PRC2 enzymatic activity. Jarid2 methylation promotes PRC2 activity at loci devoid of H3K27me3 and is required for correct H3K27me3 deposition during cell differentiation.\",\n      \"method\": \"In vitro methylation assay, mass spectrometry identification of methylated residue, EED binding assay, allosteric activation assay, cell differentiation H3K27me3 ChIP\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with biochemical identification of modification site, functional allosteric assay, and cellular validation\",\n      \"pmids\": [\"25620564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Jarid2 contains a ubiquitin interaction motif (UIM) at its amino-terminus that directly binds mono-ubiquitylated H2A lysine 119 (H2AK119u1), mediating PRC2 localization to H2AK119u1-marked chromatin both in vitro and in vivo, thereby linking PRC1 and PRC2 activities.\",\n      \"method\": \"Identification of UIM by sequence analysis, in vitro ubiquitin binding assay, Co-IP, ChIP in cells with H2AK119u1 manipulation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro binding with defined domain, in vivo ChIP validation, mutagenesis of UIM domain\",\n      \"pmids\": [\"27892467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cryo-EM structures of human PRC2 with cofactors JARID2 and AEBP2 show that methylated JARID2 mimics a methylated H3 tail to stimulate PRC2 activity; AEBP2 interacts with RBAP48 mimicking an unmodified H3 tail; SUZ12 interacts with all other subunits and stabilizes the complex.\",\n      \"method\": \"Cryo-electron microscopy structure determination, functional validation of cofactor interactions\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure with functional mechanistic interpretation, peer-reviewed\",\n      \"pmids\": [\"29348366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cryo-EM structure of PRC2 with JARID2 and AEBP2 bound to an H2AK119ub1-containing nucleosome reveals that JARID2 and AEBP2 each interact with one ubiquitin and the H2A-H2B surface; JARID2 stimulates PRC2 through interactions with both EED and H2AK119-ubiquitin; the presence of these cofactors partially overcomes inhibitory effects of H3K4me3 and H3K36me3 on core PRC2.\",\n      \"method\": \"Cryo-electron microscopy with designer nucleosome substrates, in vitro PRC2 activity assays\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution cryo-EM structure combined with in vitro enzymatic assays\",\n      \"pmids\": [\"33479123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A 30-amino-acid region of JARID2 mediates interactions with long noncoding RNAs (lncRNAs); lncRNA presence stimulates JARID2-EZH2 interactions in vitro and JARID2-mediated PRC2 recruitment to chromatin in vivo. The lncRNA Meg3 (from Dlk1-Dio3 locus) interacts with PRC2 via JARID2, and loss of MEG3 alters JARID2, PRC2, and H3K27me3 chromatin distribution.\",\n      \"method\": \"RNA immunoprecipitation (native and cross-linked), in vitro JARID2-EZH2 interaction assay with/without lncRNA, ChIP in cells lacking MEG3\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution of lncRNA-stimulated interaction, native and crosslinked RIP, in vivo ChIP validation\",\n      \"pmids\": [\"24374312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Jarid2 is an important mediator of Xist-induced PRC2 targeting to the inactive X chromosome during X-chromosome inactivation. The B and F repeats of Xist RNA are critical for Jarid2 recruitment via its unique N-terminal domain; Xist-induced Jarid2 recruitment occurs chromosome-wide independently of functional PRC2, and Jarid2 loss prevents efficient PRC2 and H3K27me3 enrichment on Xist-coated chromatin.\",\n      \"method\": \"RNA FISH, ChIP-seq, genetic deletion of Jarid2, domain mapping by N-terminal deletion constructs, inducible XCI system\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with genome-wide ChIP-seq, domain mapping, multiple cell systems\",\n      \"pmids\": [\"24462204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PRC2 in mouse ES cells contains at least three additional subunits beyond HeLa-defined composition: JARID2, MTF2, and esPRC2p48. JARID2, MTF2, and esPRC2p48 together (but not individually) synergistically stimulate PRC2 histone methyltransferase activity in vitro and enhance Oct4/Sox2/Klf4-mediated reprogramming.\",\n      \"method\": \"Mass spectrometry of PRC2 purified from ES cells, in vitro HMT assay with reconstituted complexes, shRNA knockdown, iPSC reprogramming assay\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution HMT assay, mass spectrometry complex identification, functional reprogramming assay\",\n      \"pmids\": [\"21732481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Jmj (Jarid2) represses cyclin D1 transcription through a protein complex with histone H3-K9 methyltransferases G9a and GLP; Jmj binds the cyclin D1 promoter and recruits G9a and GLP to increase H3-K9 methylation. Inactivation of both G9a and GLP (but not G9a alone) abolishes Jmj-mediated H3-K9 methylation and cyclin D1 repression.\",\n      \"method\": \"Co-immunoprecipitation (Jmj-G9a, Jmj-GLP), in vitro HMT assay, ChIP at cyclin D1 promoter, double-knockdown epistasis (G9a and GLP)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — Co-IP, in vitro HMT assay, ChIP, and epistasis experiment in single study\",\n      \"pmids\": [\"19010785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Drosophila Jarid2 physically associates with all canonical PRC2 components (conserved with mammals), and loss-of-function of Jarid2 in flies selectively affects H3K27 methylation (among several histone modifications tested) without affecting other marks, confirming Jarid2 as a conserved PRC2 interactor that specifically regulates H3K27me3.\",\n      \"method\": \"Affinity purification of Drosophila Jarid2 and mass spectrometry, genetic mutant analysis with histone modification antibodies, genome-wide ChIP-seq (Jarid2, Su(z)12, H3K27me3)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biochemical purification + mass spectrometry, genetic mutants, genome-wide ChIP-seq\",\n      \"pmids\": [\"22354997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"JARID2 overrides geometrically defined preferences of core PRC2 for propagating H3K27 methylation on designer chromatin substrates and promotes de novo deposition of H3K27me3. Phosphorylation of JARID2 can partially regulate its ability to stimulate PRC2 activity.\",\n      \"method\": \"In vitro HMT assays with designer chromatin substrates (semisynthetic nucleosome arrays), phosphorylation assays\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — rigorous in vitro reconstitution with designer substrates, single lab\",\n      \"pmids\": [\"31479253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Endothelial-specific deletion of Jarid2 (using Cre-loxP) recapitulates cardiac hypertrabeculation and ventricular noncompaction observed in whole-body Jarid2 knockouts; Jarid2 occupies the Notch1 genomic locus (ChIP) and its deletion leads to increased endocardial Notch1 expression and downstream Notch signaling.\",\n      \"method\": \"Conditional knockout (tissue-specific Cre-loxP), microarray, quantitative ChIP at Notch1 locus, Notch signaling pathway analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional genetic knockout with specific cellular phenotype and direct ChIP evidence at target locus\",\n      \"pmids\": [\"21402699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Jarid2 interacts with SETDB1 (a H3K9 methyltransferase) as identified by yeast two-hybrid and confirmed by co-immunoprecipitation; Jarid2 deletion reduces H3K9 methylation at the Notch1 locus in embryonic hearts and reduces SETDB1 accumulation at sites of Jarid2 occupancy.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, ChIP at Notch1 locus in KO vs. WT hearts, genome-wide ChIP-chip for H3K9me targets\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid confirmed by Co-IP, ChIP in genetic KO cardiac tissue\",\n      \"pmids\": [\"22110129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IFN-γ/CIITA signaling induces sequential recruitment of JARID2 and then PRC2 to muscle gene promoters; CIITA first interacts with JARID2, causing RNA Pol II (Ser5-phosphorylated) to pause, then additional PRC2 subunits including EZH2 are recruited in a JARID2-dependent manner, concurrent with H3K27 methylation and repression of myogenic genes.\",\n      \"method\": \"Co-immunoprecipitation (CIITA-JARID2), ChIP (sequential recruitment), gene expression analysis, JARID2-dependent rescue experiments\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, ChIP for sequential recruitment, JARID2-dependency established by knockdown\",\n      \"pmids\": [\"24327761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Jarid2 is upregulated by TCR signaling and during positive selection in the thymus; Jarid2 binds the Zbtb16 (PLZF) locus and its loss increases PLZF expression with decreased H3K9me3 at this locus, controlling iNKT cell maturation. Jarid2 is reported as a component of three lysine methyltransferase complexes: PRC2 (H3K27), GLP-G9a (H3K9), and SETDB1 (H3K9).\",\n      \"method\": \"ChIP at Zbtb16/PLZF locus, genetic knockout (T cell-specific), flow cytometry, H3K9me3 and H3K27me3 ChIP\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and genetic KO with defined phenotype, single lab, complex membership claim for GLP-G9a and SETDB1 inferred from prior literature rather than direct biochemical reconstitution in this paper\",\n      \"pmids\": [\"25105474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Deletion of Jarid2 in mouse epidermis reduces proliferation and potentiates differentiation of postnatal epidermal progenitors; Jarid2 deficiency reduces H3K27me3 at PRC2-target epidermal differentiation genes in neonatal epidermis, and causes delayed hair follicle cycling due to decreased proliferation of HF stem cells.\",\n      \"method\": \"Conditional knockout (epidermis-specific), H3K27me3 ChIP, BrdU proliferation assay, histological analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional genetic KO with H3K27me3 ChIP confirming mechanistic link to PRC2 activity\",\n      \"pmids\": [\"21811233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"JARID2 is a direct transcriptional target of the PAX3-FOXO1 fusion protein; JARID2 silencing induces myogenic differentiation (increased MYOG, MYL1 expression); JARID2 binds the MYOG and MYL1 promoters and alters H3K27me3 there in an EED-dependent manner.\",\n      \"method\": \"ChIP at MYOG/MYL1 promoters, luciferase reporter for PAX3-FOXO1 direct targeting, siRNA knockdown, overexpression rescue\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay in RMS cell lines, single lab\",\n      \"pmids\": [\"23435416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Jarid2-cyclin D1 genetic epistasis in mouse cardiomyocytes: Jmj/cyclin D1 double-mutant mice show that Jmj is required for normal cardiomyocyte differentiation and GATA4 protein expression through repression of cyclin D1. CDK4 (activated by cyclin D1) phosphorylates GATA4 directly, promoting its degradation in cultured cells.\",\n      \"method\": \"Double-mutant mouse genetics (Jmj/cyclin D1), transgenic overexpression, in vitro kinase assay (CDK4 phosphorylation of GATA4), rescue by exogenous GATA4\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genetic epistasis in vivo, in vitro kinase assay, transgenic rescue\",\n      \"pmids\": [\"21447557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"JARID2 and the PRC2 complex regulate skeletal muscle differentiation by directly repressing the Wnt antagonist SFRP1; depletion of JARID2 causes upregulation of SFRP1, which blocks MYOD and β-catenin nuclear translocation required for differentiation. ChIP confirmed JARID2 and EZH2 occupancy and H3K27me3 at the SFRP1 locus.\",\n      \"method\": \"ChIP-seq, ChIP-PCR (JARID2, EZH2, H3K27me3 at SFRP1), shRNA depletion, Wnt pathway rescue (β-catenin nuclear translocation), ectopic SFRP1 expression\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq combined with genetic depletion and functional pathway rescue, direct target identification\",\n      \"pmids\": [\"30119689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"JARID2 and the PRC2 complex regulate the skeletal muscle cell cycle by directly repressing cyclin D1 and cyclin E1 (targets of PRC2-mediated H3K27me3) and repressing RB1; depletion of JARID2 increases proliferation and S-phase accumulation. Ectopic RB1 expression can suppress cyclin D1 in JARID2-depleted cells.\",\n      \"method\": \"ChIP at cyclin D1, cyclin E1, and RB1 promoters; shRNA stable depletion; flow cytometry cell cycle analysis; ectopic expression rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and genetic depletion with cell cycle readout, single lab\",\n      \"pmids\": [\"31578284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Jarid2 physically and functionally interacts with zinc finger protein Zfp496 (identified by yeast two-hybrid); Zfp496 functions as a transcriptional activator and inhibits Jarid2-mediated transcriptional repression, while Jarid2 represses Zfp496-mediated transcriptional activation.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation, transcriptional reporter assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — yeast two-hybrid confirmed by Co-IP and reporter assay, single lab\",\n      \"pmids\": [\"17521633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Nkx2.5 directly regulates Jarid2 expression in second heart field progenitors; Nkx2.5 occupies consensus binding sites in the Jarid2 promoter (ChIP), and Nkx2.5 overexpression down-regulates Jarid2 promoter activity and mRNA levels.\",\n      \"method\": \"ChIP at Jarid2 promoter in pharyngeal arch cells, promoter-luciferase reporter assay, overexpression\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase reporter, single lab\",\n      \"pmids\": [\"20549724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Jarid2 inhibition of JARID2 in hematopoietic stem and progenitor cells (HSPCs) enhances competitive transplantation capacity in mice (similar to Suz12 depletion); JARID2 depletion enhances in vitro expansion and in vivo reconstitution of human HSPCs. Gene expression profiling identified common Suz12 and Jarid2 target genes enriched for H3K27me3.\",\n      \"method\": \"Competitive bone marrow transplantation, shRNA knockdown, human HSPC expansion assay, gene expression profiling, H3K27me3 ChIP\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional in vivo transplantation assay, single lab\",\n      \"pmids\": [\"25645357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"JARID2 promotes iPSC reprogramming by suppressing Arf expression (a known reprogramming barrier); the N-terminal half of JARID2 is sufficient for this promotion. JARID2 physically interacts with ESRRB, SALL4A, and PRDM14, and these JARID2-associated proteins synergistically facilitate iPSC reprogramming in a JARID2-dependent manner. JARID2 also accelerates silencing of retroviral Klf4 transgene and demethylation of the Nanog promoter.\",\n      \"method\": \"Co-immunoprecipitation (JARID2-ESRRB, JARID2-SALL4A, JARID2-PRDM14), N-terminal deletion mapping, iPSC reprogramming efficiency assay, bisulfite sequencing (Nanog promoter), domain rescue experiments\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and domain mapping combined with functional reprogramming assay, single lab\",\n      \"pmids\": [\"26523946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In lineage-committed human keratinocytes (unlike ES cells), JARID2 predominantly exists as a novel low-molecular-weight form (ΔN-JARID2) lacking the N-terminal PRC2-interacting domain, generated by proteolytic cleavage. ΔN-JARID2 (lacking PRC2 interaction) can rescue repression of epidermal differentiation genes in JARID2-null keratinocytes, suggesting a PRC2-independent function in promoting differentiation gene activation.\",\n      \"method\": \"Western blotting (size determination), JARID2 knockout (keratinocytes), rescue by ΔN-JARID2 expression, RNA-seq of JARID2-null cells\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with rescue by domain-deletion construct, single lab\",\n      \"pmids\": [\"30573669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Jarid2-deficient ES cells express constitutively high levels of Nanog and reduced PCP signaling components (Wnt9a, Prickle1, Fzd2) and lowered β-catenin activity; depletion of Wnt9a/Prickle1/Fzd2 or overexpression of Nanog phenocopies Jarid2-deficient differentiation block. Co-culture of Jarid2-/- with wild-type ESCs restores variable Nanog expression and β-catenin activity.\",\n      \"method\": \"Genetic knockout, gene expression profiling, Nanog overexpression rescue, co-culture experiments, blastocyst injection\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic approaches and co-culture rescue, single lab\",\n      \"pmids\": [\"26190104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"JARID2 is involved in TGF-β-induced epithelial-mesenchymal transition; ChIP assays showed JARID2 is recruited to CDH1 and miR-200 family gene regulatory regions during TGF-β treatment, where it regulates H3K27me3 levels and EZH2 occupancy to mediate transcriptional repression of these EMT-suppressor genes.\",\n      \"method\": \"ChIP (JARID2, EZH2, H3K27me3 at CDH1 and miR-200 loci), siRNA knockdown, TGF-β treatment, gene expression analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at specific target loci, genetic depletion with pathway phenotype, single lab\",\n      \"pmids\": [\"25542019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"JARID2 promotes HCC invasion and metastasis by repressing PTEN expression through increasing H3K27me3 at the PTEN promoter, which activates AKT and enhances EMT.\",\n      \"method\": \"ChIP at PTEN promoter (H3K27me3), siRNA knockdown and overexpression, in vitro invasion/migration assays, xenograft metastasis model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at target locus combined with functional invasion assay, single lab\",\n      \"pmids\": [\"27259236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"JARID2 negatively regulates CCND1 (cyclin D1) expression in leukemia cells by increasing H3K27 trimethylation at the CCND1 promoter; knockdown of JARID2 promotes G1/S transition and proliferation, while ectopic JARID2 expression inhibits these phenotypes.\",\n      \"method\": \"ChIP (JARID2 and H3K27me3 at CCND1 promoter), siRNA knockdown, ectopic overexpression, flow cytometry cell cycle analysis\",\n      \"journal\": \"International journal of hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at target locus, gain- and loss-of-function, single lab\",\n      \"pmids\": [\"25939703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Jarid2 is required for late-stage differentiation of embryonic pancreatic β-cells; conditional ablation in pancreatic progenitors reduces endocrine cell area and impairs β-cell differentiation program. Jarid2-deficient pancreases show impaired deposition of RNAPII-Ser5P (initiating Pol II) but no changes in H3K27me3 at affected endocrine gene promoters, indicating a PRC2-independent mechanism.\",\n      \"method\": \"Conditional knockout (pancreas-specific Cre), genome-wide expression analysis, ChIP (H3K27me3 and RNAPII-Ser5P at endocrine gene promoters)\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with ChIP evidence for PRC2-independent mechanism, single lab\",\n      \"pmids\": [\"28912479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Jarid2 regulates the transition from early to late retinal progenitor competence by maintaining H3K27me3 repression of Foxp1; loss of Jarid2 reduces H3K27me3 on Foxp1 and other early progenitor genes, leading to extended production of early-born cell types. Foxp1 is required for extending early retinal cell production after Jarid2 loss (genetic epistasis).\",\n      \"method\": \"Conditional knockout (retinal progenitor), ChIP (H3K27me3 at Foxp1 and early progenitor gene loci), genetic epistasis (Jarid2/Foxp1 double manipulation), birthdating assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at target loci, genetic epistasis with two-gene manipulation, single lab\",\n      \"pmids\": [\"36924502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Jarid2 mediates H3K27me3-dependent repression of p16 in bladder cancer tumor-initiating cells; knockdown of Jarid2 upregulates p16 with increased H3K27me3 at the p16 promoter region, and reduces sphere-forming capacity and tumorigenicity of bladder cancer TICs in vivo.\",\n      \"method\": \"ChIP at p16 promoter, siRNA knockdown, sphere formation assay, in vivo tumorigenicity assay\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single ChIP assay and single lab; note finding is somewhat contradictory (knockdown of Jarid2 increases H3K27me3 at p16 which is mechanistically inconsistent; likely a reporting issue)\",\n      \"pmids\": [\"31125562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Myocardial-specific ablation of Jarid2 (αMHC::Cre) causes dilated cardiomyopathy and premature death; Jarid2 is required to repress fetal contractile genes (Tnni1, Acta2) in neonatal stages through ErbB4 signaling, and its loss prevents normal induction of adult contractile gene expression.\",\n      \"method\": \"Conditional knockout (αMHC-Cre), gene expression profiling, pathway analysis, ErbB4 signaling analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional cardiac-specific KO with defined DCM phenotype and gene expression pathway analysis, single lab\",\n      \"pmids\": [\"30700554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Deletion of Jarid2 by Nkx2.5-Cre (cardiac progenitors) causes ventricular septal defects, thin myocardium, hypertrabeculation, and neonatal lethality; Jarid2 is required for PRC2 occupancy and H3K27me3 at the Isl1 promoter in the myocardium, and its deletion elevates Isl1, Bmp10, and neural gene expression.\",\n      \"method\": \"Conditional knockout (Nkx2.5-Cre), ChIP (H3K27me3 and PRC2 at Isl1 promoter), genome-wide ChIP-seq, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with target-specific ChIP evidence, genome-wide analysis, single lab\",\n      \"pmids\": [\"29891551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"JARID2 knockdown in mouse multipotent progenitors enhances T-cell output (distinct from EZH2 loss which increases myeloid differentiation), suggesting JARID2 has PRC2-independent functions in hematopoiesis; mechanistically, JARID2 knockdown in human UCB HSPCs promotes a quiescent long-term self-renewal gene expression program via upregulation of STAT1 and MHC class II immunophenotype, conferring HSC-like potential to human MPPs in vivo.\",\n      \"method\": \"Genetic comparison of Jarid2 vs. Ezh2 conditional KO, single-cell transcriptomics, competitive transplantation, human HSPC functional assays in vivo\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-cell transcriptomics combined with functional in vivo transplantation, preprint not yet peer-reviewed\",\n      \"pmids\": [\"40791535\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In Drosophila spermatogenesis, dJmj (Jarid2) localizes exclusively to the nucleolus at late growth stage in a Polycomb-dependent manner; Polycomb (Pc) interacts with dJmj at the nucleolus (confirmed by Proximity Ligation Assay), and tTAF is responsible for Pc-mediated recruitment of dJmj to the nucleolus. H3K27me3 levels decrease in nuclei at this stage, correlating with nucleolar sequestration of dJmj.\",\n      \"method\": \"Immunocytochemistry, Duolink In Situ Proximity Ligation Assay (Pc-dJmj interaction), PcG mutant analysis, tTAF mutant analysis\",\n      \"journal\": \"Spermatogenesis\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — localization study with PLA interaction assay, single lab, Drosophila model, limited functional follow-up\",\n      \"pmids\": [\"28144496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"JARID2 physically interacts with the NuRD complex (identified by immunoaffinity purification and silver staining mass spectrometry, confirmed by Co-IP and GST pull-down) in breast cancer cells; JARID2-NuRD co-occupies and represses tumor suppressor genes BRCA2, RB1, and INPP4B (confirmed by ChIP-seq and ChIP-reChIP assays).\",\n      \"method\": \"Immunoaffinity purification + mass spectrometry, Co-IP, GST pull-down, ChIP-seq, ChIP-PCR, ChIP-reChIP\",\n      \"journal\": \"Cancer communications (London, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical methods (MS, Co-IP, GST pull-down, ChIP-seq), single lab\",\n      \"pmids\": [\"37658635\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"JARID2 is a catalytically inactive, multifunctional regulatory subunit of Polycomb Repressive Complex 2 (PRC2) that promotes PRC2 recruitment to target chromatin—via recognition of H2AK119ub1 through its N-terminal ubiquitin interaction motif and via lncRNA-mediated bridging—while simultaneously acting as a substrate for PRC2-mediated methylation; this JARID2 methylation is recognized by EED and allosterically activates PRC2, creating a positive feedback loop for H3K27me3 deposition. In a context-dependent manner, JARID2 also associates with H3K9 methyltransferases (G9a/GLP, SETDB1, SETDB1) to repress target genes such as cyclin D1 and Notch1, and in lineage-committed cells exists as a cleaved N-terminally truncated form that functions independently of PRC2 to promote differentiation gene activation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"JARID2 is a chromatin-associated regulatory subunit of Polycomb Repressive Complex 2 (PRC2) that calibrates the genomic targeting and enzymatic output of H3K27me3 deposition at developmental genes [#0, #1]. It is a stable PRC2 component required for the bulk of PRC2 occupancy across PcG target genes and is sufficient to recruit PRC2 to a heterologous promoter, with its loss collapsing PRC2 binding and H3K27me3 [#0]. JARID2 directs PRC2 to chromatin through multiple recruitment modes: an N-terminal ubiquitin interaction motif that binds H2AK119ub1 to couple PRC1 and PRC2 activities [#4], and a discrete RNA-binding region that engages long noncoding RNAs—including Meg3 and Xist—to bridge PRC2 to target loci and to the inactive X chromosome [#7, #8]. Beyond recruitment, JARID2 is itself a PRC2 substrate: EZH2-mediated methylation of JARID2 is read by EED and allosterically activates PRC2, and structural work shows methylated JARID2 mimics a methylated H3 tail while contacting both EED and H2AK119-ubiquitin to stimulate methyltransferase activity, enabling de novo H3K27me3 deposition even on substrates that disfavor core PRC2 [#3, #5, #6, #12]. Through these activities JARID2 governs cell-fate decisions in ES cells, cardiac and endothelial development, epidermal and skeletal-muscle differentiation, and hematopoiesis, frequently by PRC2-dependent repression of specific targets such as Notch1, Isl1, cyclin D1, SFRP1, and PTEN [#13, #17, #20, #21, #29, #35]. In a context-dependent manner JARID2 also acts outside canonical PRC2: it partners with the H3K9 methyltransferases G9a/GLP and SETDB1 to repress cyclin D1 and Notch1 [#10, #14], associates with the NuRD complex to silence tumor-suppressor genes [#38], and in lineage-committed keratinocytes exists as an N-terminally cleaved form (\\u0394N-JARID2) lacking the PRC2-interacting domain that promotes differentiation-gene activation independently of PRC2 [#26].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Before its PRC2 role was known, JARID2 (Jmj) was shown to act as a transcriptional repressor by templating H3K9 methylation, establishing it as a chromatin-modifying scaffold rather than an independent enzyme.\",\n      \"evidence\": \"Co-IP, in vitro HMT assay, ChIP, and G9a/GLP double-knockdown epistasis at the cyclin D1 promoter\",\n      \"pmids\": [\"19010785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish JARID2's relationship to PRC2 or H3K27 methylation\", \"Mechanism of JARID2 recruitment to the cyclin D1 promoter not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"JARID2 was defined as a bona fide PRC2 subunit that simultaneously promotes PRC2 recruitment yet inhibits its in vitro activity, framing it as a 'molecular rheostat' for developmental gene regulation.\",\n      \"evidence\": \"Co-IP, genome-wide ChIP-seq of Jarid2/Ezh2/Suz12, in vitro HMT assay \\u00b1 Jarid2, Xenopus knockdown\",\n      \"pmids\": [\"20064375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The apparent in vitro inhibition versus in vivo recruitment paradox unresolved\", \"No structural basis for the activity modulation\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Multiple studies established that JARID2 is genome-wide required for PRC2 occupancy and for co-recruitment of PRC1 and paused RNA Pol II, defining it as the principal targeting determinant of PRC2 in ES cells.\",\n      \"evidence\": \"Reciprocal Co-IP, genome-wide ChIP-seq, heterologous promoter recruitment assay, Jarid2-null ES cells with chromatin profiling\",\n      \"pmids\": [\"20075857\", \"20473294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which JARID2 selects target loci not yet defined\", \"Did not explain how recruitment is coupled to enzymatic activation\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"JARID2 was shown to be a conserved PRC2 cofactor whose loss specifically affects H3K27me3, and to synergize with MTF2 and esPRC2p48 to stimulate PRC2 activity and reprogramming, beginning to reconcile its dual recruitment/activity roles.\",\n      \"evidence\": \"Mass spectrometry of ES-cell PRC2, reconstituted in vitro HMT assays, Drosophila genetic mutants and ChIP-seq, iPSC reprogramming assay\",\n      \"pmids\": [\"21732481\", \"22354997\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cofactor combinations physically reorganize PRC2 not yet shown\", \"Did not identify the chromatin signal driving JARID2-dependent targeting\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Tissue-specific deletions revealed that JARID2 controls discrete differentiation programs by direct repression of lineage genes, linking its molecular activity to organ development.\",\n      \"evidence\": \"Conditional Cre-loxP knockouts in endothelium and epidermis, ChIP at Notch1 and differentiation loci, H3K27me3 ChIP, proliferation assays\",\n      \"pmids\": [\"21402699\", \"21811233\", \"22110129\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cardiac repression operates through PRC2 or H3K9 routes was not fully separated\", \"Recruitment specificity to Notch1 versus other loci not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of a 30-aa lncRNA-binding region showed that noncoding RNAs (e.g., Meg3) stimulate JARID2-EZH2 interaction and PRC2 recruitment, providing one mechanism for locus-specific targeting.\",\n      \"evidence\": \"Native and cross-linked RIP, in vitro JARID2-EZH2 interaction \\u00b1 lncRNA, ChIP in MEG3-null cells\",\n      \"pmids\": [\"24374312\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Sequence/structural determinants of RNA selectivity not defined\", \"How RNA binding is coordinated with histone-mark reading unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"JARID2 was identified as the mediator of Xist-induced PRC2 targeting to the inactive X, demonstrating RNA-guided, PRC2-independent recruitment chromosome-wide.\",\n      \"evidence\": \"RNA FISH, ChIP-seq, Jarid2 deletion, N-terminal domain mapping in an inducible XCI system\",\n      \"pmids\": [\"24462204\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Xist-JARID2 contact not biochemically resolved\", \"How Xist repeats engage the N-terminal domain structurally unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"JARID2 was shown to be methylated by EZH2 and read by EED, allosterically activating PRC2\\u2014resolving the recruitment-versus-activity paradox by revealing a positive feedback loop seeding H3K27me3 de novo.\",\n      \"evidence\": \"In vitro methylation, mass spectrometry site identification, EED binding and allosteric activation assays, differentiation H3K27me3 ChIP\",\n      \"pmids\": [\"25620564\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetics of methylation versus recruitment in vivo not measured\", \"How the feedback loop is restricted to correct loci unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A ubiquitin interaction motif was found to bind H2AK119ub1, defining a direct chromatin-mark-reading mechanism that couples PRC1-deposited ubiquitin to PRC2 localization.\",\n      \"evidence\": \"Sequence-based UIM identification, in vitro ubiquitin binding, Co-IP, ChIP under H2AK119ub1 manipulation, UIM mutagenesis\",\n      \"pmids\": [\"27892467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of UIM versus lncRNA recruitment in vivo not quantified\", \"Structural geometry of UIM-ubiquitin engagement not yet shown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Cryo-EM structures provided the physical basis for JARID2 stimulation of PRC2, showing methylated JARID2 mimics a methyl-H3 tail and stabilizes the active complex with AEBP2.\",\n      \"evidence\": \"Cryo-EM of human PRC2 with JARID2 and AEBP2, functional validation of cofactor interactions\",\n      \"pmids\": [\"29348366\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure lacked a nucleosome substrate\", \"Did not resolve the H2AK119ub1-bound configuration\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A nucleosome-bound cryo-EM structure unified the recruitment and activation mechanisms, showing JARID2 contacts both EED and H2AK119-ubiquitin and helps overcome inhibitory active marks.\",\n      \"evidence\": \"Cryo-EM with designer H2AK119ub1 nucleosomes, in vitro PRC2 activity assays\",\n      \"pmids\": [\"33479123\", \"31479253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of overriding H3K4me3/H3K36me3 inhibition not directly tested\", \"Role of JARID2 phosphorylation in this geometry not structurally resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"JARID2 was shown to act through non-PRC2 routes\\u2014partnering with NuRD and existing as a cleaved \\u0394N-JARID2 in committed cells\\u2014revealing that its function is context-dependent and not strictly PRC2-bound.\",\n      \"evidence\": \"Western blot size determination, keratinocyte knockout with \\u0394N-JARID2 rescue, RNA-seq; immunoaffinity MS, Co-IP, GST pull-down, ChIP-reChIP for NuRD\",\n      \"pmids\": [\"30573669\", \"37658635\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Protease generating \\u0394N-JARID2 not identified\", \"How \\u0394N-JARID2 activates differentiation genes mechanistically unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Comparison of Jarid2 versus Ezh2 loss in hematopoietic progenitors indicated PRC2-independent control of self-renewal and lineage output, distinguishing JARID2's regulatory roles from core PRC2.\",\n      \"evidence\": \"Conditional KO comparison, single-cell transcriptomics, competitive transplantation, human HSPC assays (preprint)\",\n      \"pmids\": [\"40791535\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"Molecular basis of STAT1/MHC-II upregulation by JARID2 loss not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How JARID2's distinct recruitment modes (H2AK119ub1, lncRNA, sequence-specific factors) and its PRC2-independent partnerships (G9a/GLP, SETDB1, NuRD, \\u0394N-JARID2) are selected and balanced across cell types remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating ubiquitin-reading, RNA-bridging, and methylation feedback at single loci\", \"Determinants switching JARID2 between PRC2 and H3K9/NuRD complexes unknown\", \"Identity and regulation of the \\u0394N-JARID2 cleavage event undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [3, 5]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [7, 8]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [10, 22]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 4, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [4, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [10, 20, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [13, 17, 20, 35]}\n    ],\n    \"complexes\": [\"PRC2\", \"G9a/GLP (H3K9 methyltransferase complex)\", \"SETDB1 complex\", \"NuRD\"],\n    \"partners\": [\"EZH2\", \"SUZ12\", \"EED\", \"AEBP2\", \"G9a\", \"GLP\", \"SETDB1\", \"MTF2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}